Drug Shortage Report for ANDRODERM
Report ID | 131988 |
Drug Identification Number | 02239653 |
Brand name | ANDRODERM |
Common or Proper name | testosterone |
Company Name | ALLERGAN INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TESTOSTERONE |
Strength(s) | 2.5MG |
Dosage form(s) | PATCH |
Route of administration | TRANSDERMAL TRANSDERMAL |
Packaging size | 2.5mg |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-01-13 |
Estimated end date | 2021-02-05 |
Actual end date | 2021-01-20 |
Shortage status | Resolved |
Updated date | 2021-01-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-01-21 | English | Compare |
v4 | 2021-01-20 | French | Compare |
v3 | 2021-01-20 | English | Compare |
v2 | 2021-01-19 | French | Compare |
v1 | 2021-01-19 | English | Compare |
Showing 1 to 5 of 5